Neurological manifestations in pediatric COVID-19: a comparative single-center study, 2026, Ibrahim et al.

Chandelier

Senior Member (Voting Rights)
Neurological manifestations in pediatric COVID-19: a comparative single-center study

Ibrahim, Hanan; Mansour, Mervat; Ahmed, Ahmed R.; Rushdy, Marwa; ElGammal, Mona Mostafa; Zaitoun, Raghda

Abstract

Objective

To compare clinical characteristics, investigations, management, and outcomes of hospitalized children with SARS-CoV-2 infection with and without neurological involvement, and to determine whether neurological disease reflects systemic severity or a distinct clinical pattern.

Methods
We conducted a retrospective observational study of children aged 1 month–16 years with laboratory-confirmed SARS-CoV-2 infection admitted to a tertiary pediatric center between June 2022 and June 2023. Patients were divided into those with neurological manifestations (ND group, n = 24) and those without neurological involvement (non-ND group, n = 23). Demographic features, clinical presentation, laboratory and neuroimaging findings, treatment, and outcomes were compared.

Results
Children with neurological involvement were significantly older (median 5.75 vs. 3.00 years, p = 0.022) and less likely to present with fever or systemic inflammatory features. They demonstrated lower inflammatory markers and significantly less cardiac involvement, including dilated cardiomyopathy.

Common neurological presentations included encephalopathy (50%), headache (45.8%), and seizures (20.8%). 37% met MIS-C criteria. Neuroimaging revealed lacunar infarctions, demyelinating white matter lesions, longitudinally extensive transverse myelitis, and cauda equina nerve root enhancement.

Despite similar mortality rates, children with neurological involvement had a significantly higher rate of incomplete recovery, with more than a quarter experiencing persistent neurological sequelae (29.2% vs. 4.3%, p = 0.048).

Conclusion
Neurological manifestations of pediatric COVID-19 represent a clinically distinct pattern characterized by limited systemic inflammation but an increased risk of persistent neurological sequelae.

Early neurological evaluation, appropriate neuroimaging, and structured long-term follow-up are warranted even in the absence of severe systemic illness.

Web | DOI | PDF | Acta Neurologica Belgica 2026 | Open Access
 
Back
Top Bottom